The investment arm of one of the world’s biggest insurers just made major changes in its U.S.-traded investments, selling off 2024 winners and buying up a laggard. MEAG Munich Ergo Asset ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback